Microsoft word - tobacco use cessation counseling form.doc

TOBACCO USE CESSATION COUNSELING
INITIAL ASSESSMENT
PATIENT: ________________________________________ DATE: _____/_____/_________
(Last Name) (First Name)
Do you currently smoke or use any type of tobacco product?
YES NO
Have you ever smoked or used any type of tobacco product in the past?
YES NO
IF YOU ANSWERED “NO” TO THE ABOVE QUESTIONS, YOU DO NOT NEED TO
CONTINUE COMPLETION OF THIS FORM. IF YOU ANSWERED “YES” TO THE
EITHER QUESTION, PLEASE CONTINUE.
What forms of tobacco do (did) you use? (Cigarettes, cigars, pipe, chewing tobacco, loose
leaf tobacco, other) – please list below:
___________________________________________________________________________
____________________________________________________________________________
On a daily basis, how often or how much tobacco do (did) you use? ___________________
Are you interested in receiving counseling and treatment options from your physician for
tobacco use cessation (quitting)?
YES NO

IF YES, THEN PLEASE ANSWER THE REMAINING QUESTIONS.

Have you tried to quit using tobacco in the past? ______________________________
What methods of quitting have you tried? ____________________________________
________________________________________________________________________
Why do you feel you have been unable to quit? ________________________________
________________________________________________________________________

__________________PATIENT STOP HERE__________________

Physician’s suggestions:
Nicotine Replacement Therapy
Zyban/Wellbutrin
Chantix
Behavior Modification
Situational Avoidance
Oral Substitution
Other _____________________________________________________________________
Return for follow up: _________________________________________________________
Physician Signature: ____________________________ DATE: ______/______/__________

NOTE: Please print and bring to your appointment. PCCS-Tobacco Use Initial (02/2013)
TOBACCO USE CESSATION COUNSELING
FOLLOW UP ASSESSMENT

PATIENT: ________________________________________ DATE: _____/_____/_________
(Last Name) (First Name)

Are you still continuing to smoke or use any type of tobacco product? YES NO

IF YOU ANSWERED “NO” TO THE ABOVE QUESTION, YOU DO NOT NEED TO
CONTINUE COMPLETION OF THIS FORM. IF YOU ANSWERED “YES” TO THE
ABOVE QUESTION, PLEASE CONTINUE THIS FORM.
Do you feel you have been able to decrease your tobacco use? ________________________
On a daily basis, how often or how much tobacco do you use? ________________________
Which method(s) have been the most helpful in decreasing your tobacco use? ___________
_____________________________________________________________________________
What do you feel is still your biggest deterrent for quitting? __________________________
______________________________________________________________________________
__________________PATIENT STOP HERE__________________
Physician’s suggestions:
Nicotine Replacement Therapy
Zyban/Wellbutrin
Chantix
Behavior Modification
Situational Avoidance
Oral Substitution
Other _____________________________________________________________________
_____________________________________________________________________________
Return for follow up: __________________________________________________________
Physician Signature: ____________________________ DATE: ______/______/__________
NOTE: Please print and bring to your appointment.
PCCS-Tobacco Use Initial (02/2013)

Source: http://www.pccsnova.com/forms/nvpccs_Tobacco_Counseling_Form.pdf

Outline of exxon risk & climate resolution

EXXONMOBIL: REPORT TO SHAREOWNERS ON FINANCIAL RISKS RESULTING FROM CLIMATE CHANGE AND ITS IMPACT ON SHAREOWNER VALUE Whereas: There is general consensus among climate scientists that, without significant intervention, climate change will result in dramatic weather events, rising sea levels, drought in some areas, and significant impacts on human and ecosystem health. The Pentagon

Progrmme_nanosms_081113

Introduction : présentation de NanoSMS (Jérémie Léonard, IPCMS) Surfaces fonctionalisées et nanostructurées pour applications biomédicales : Nadia Jessel, UMR 595, Faculté de Chirurgie Dentaire: « Nanostructured and Multilayered Active Materials for Clinical Applications” Lydie Ploux, ICSI, Mulhouse : « Adhésion de cellules osseuses humaines et de bactéries sur des surfac

Copyright © 2009-2018 Drugs Today